diabetestalk.net

Ascensia Diabetes Care Parsippany Nj

Mack-cali Announces New Lease With Ascensia Diabetes Care

Mack-cali Announces New Lease With Ascensia Diabetes Care

Mack-Cali announces new lease with Ascensia Diabetes Care Mack-Cali announces new lease with Ascensia Diabetes Care Global Leader in Blood Glucose Monitoring and Diabetes Care Solutions will Open U.S. Headquarters in Parsippany PARSIPPANY Mack-Cali Realty Corporation announced that Ascensia Diabetes Care US, Inc., a leader in blood glucose monitoring that is owned by Panasonic Healthcare Holdings Co., Ltd. and leading global investment firm KKR, will bring their U.S. headquarters to FiveWood Hollow Road. Ascensia signed a lease for 43,534 square feet for over 10 years. The award-winning Mack-Cali property is a 317,040-square-foot, three-story, class A office building in Morris County with easy highway access, a sophisticated infrastructure, and outstanding amenities. Ascensia joins AIG, Coyne PR, Groupe SEB, The MI Group, and Decision Resources to bring this trophy asset to 98.6 percent leased. This building is the ideal home for Ascensias U.S. headquarters, providing all the conveniences and services a company of this significance needs, said Christopher DeLorenzo, Mack-Cali executive vice president of leasing. Mack-Calis strategic plan focuses on our core properties like FiveWood Hollow Road that bring together premier office space, ideal transportation options, and the amenities to create workplaces where employees want to work. Strategically located and beautifully renovated, FiveWood Hollow Road is LEED Gold certified by the U.S. Green Building Council. It is located at the nexus of I-287 and I-80, with I-280, and routes 202, 46, and 10 all nearby, giving tenants easy commuting access. The building boasts a range of amenities including a contemporary, three-story renovated atrium lobby, an on-site, full-service cafeteria with indoor and outdoor seating, compliment Continue reading >>

Ascensia Diabetes Care Leases At 5 Wood Hollow Rd.

Ascensia Diabetes Care Leases At 5 Wood Hollow Rd.

Ascensia Diabetes Care Leases at 5 Wood Hollow Rd. PARSIPPANY, NJAscensia Diabetes Care US, a leader in blood glucose monitoring, will bring its US headquarters to Mack-Calis 5 Wood Hollow Road in Parsippany, NJ. Your article was successfully shared with the contacts you provided. Get alerted any time new stories match your search criteria. Create an alert to follow a developing story, keep current on a competitor, or monitor industry news. Dont forget you can visit MyAlerts to manage your alerts at any time. PARSIPPANY, NJAscensia Diabetes Care US, a leader in blood glucose monitoring owned by Panasonic Healthcare Holdings and global investment firm KKR, will bring its US headquarters to 43,534 square feet of space in Mack-Calis 5 Wood Hollow Road in Parsippany, NJ. Steve Lubetkin is the New Jersey and Philadelphia editor for GlobeSt.com. He is filling in covering Atlanta until a permanent editor is named. Steves journalism background includes print and broadcast reporting for NJ news organizations. His audio and video work for GlobeSt.com has been honored by the Garden State Journalists Association , and he has also been recognized for video by the New Jersey Chapter of the Society of Professional Journalists . He has produced audio podcasts on CRE topics for the NAR Commercial Division and the CCIM Institute. Steve has also served (from August 2017 to March 2018) as national broadcast news correspondent for CEOReport.com, a news website focused on practical advice for senior executives in small- and medium-sized companies. Steve also reports on-camera and covers conferences for NJSpotlight.com, a public policy news coverage website focused on New Jersey government and industry; and for clients of StateBroadcastNews.com , a division of The Lubetkin Media Companies LL Continue reading >>

U.s. Headquarters: Ascensia Diabetes Care Signs Lease With Mack-cali

U.s. Headquarters: Ascensia Diabetes Care Signs Lease With Mack-cali

U.S. headquarters: Ascensia Diabetes Care signs lease with Mack-Cali Mack-Cali announces a new 43,534-square-foot lease with Ascensia Diabetes Care US Inc.Special to NJ.com Mack-Cali Realty Corp. has announced that Ascensia Diabetes Care US Inc. will bring its U.S. headquarters to 5 Wood Hollow Road in Parsippany. Ascensia, a leader in blood glucose monitoring owned by Panasonic Healthcare Holdings Co. Ltd. and leading global investment firm KKR, signed a lease for 43,534 square feet for more than 10 years. The award-winning Mack-Cal i property is a 317,040-square-foot, three-story, Class A office building in Morris County with easy highway access, a sophisticated infrastructure and outstanding amenities. Ascensia joins AIG, Coyne PR, Groupe SEB, The MI Group and Decision Resources to bring the asset to 98.6 percent leased. "This building is the ideal home for Ascensia's U.S. headquarters, providing all the conveniences and services a company of this significance needs," said Christopher DeLorenzo, Mack-Cali executive vice president of leasing. "Mack-Cali's strategic plan focuses on our core properties (such as) 5 Wood Hollow Road that bring together premier office space, ideal transportation options and the amenities to create workplaces where employees want to work." Strategically located and beautifully renovated, 5 Wood Hollow Road is LEED Gold certified by the U.S. Green Building Council. It is located at the nexus of Interstates 287 and 80, with I-280 and Routes 202, 46, and 10 nearby, giving tenants easy commuting access. The building boasts a range of amenities including a contemporary, three-story renovated atrium lobby, an onsite, full-service cafeteria with indoor and outdoor seating, complimentary Wi-Fi available in the cafeteria and its adjacent public mee Continue reading >>

Ascensia Diabetes Care Inks Integration Deal With Insulet

Ascensia Diabetes Care Inks Integration Deal With Insulet

Ascensia Diabetes Care inks integration deal with Insulet Ascensia Diabetes Care said today it inked a strategic alliance with Insulet (NSDQ: PODD ) to integrate connectivity between Insulets next-gen Omnipod system with Ascensias Contour Next One blood glucose monitoring system. Through the deal, Parsippany, N.J.-based Ascensias Contour Next will be designed to pair via Bluetooth with the Omnipod Dash personal diabetes manager to automatically communicate blood glucose readings directly to the system. Readings provided will be used by Insulets Omnipod Dash PDM to calculate insulin dosing and support delivery of insulin. We are thrilled to partner with Ascensia as part of our development efforts on our next-generation Omnipod Dash platform, which will allow Insulet to maintain its competitive edge with truly innovative and differentiated products, prez & COOShacey Petrovic said in a press release. Insulet will develop and seek marketing clearance for its Omnipod Dash PDM with collaboration with Ascensia Diabetes Care, who will provide the Contour Next One meter and Contour Next test strips. We are delighted to enter into this agreement that brings together these innovative technologies from both companies. The integration of our BGM system with Insulets tubeless insulin pump system has significant potential to help people take control of their lives and their diabetes. We are pleased that our highly accurate system has been chosen to provide the critical blood glucose data that will be used by the Omnipod Dash PDM to calculate insulin dosing for patients. This alliance is the next step in our goal of providing integrated solutions for people living with diabetes. We believe that integrated diabetes management is the future and are happy to work with partners that will Continue reading >>

Diabetes Device Company Picks Parsippany Building For New Hq

Diabetes Device Company Picks Parsippany Building For New Hq

Diabetes device company picks Parsippany building for new HQ By Anjalee Khemlani, January 29, 2016 at 7:00 AM A new medical device company has chosen Parsippany for its headquarters. Ascensia Diabetes Care, which was recently acquired by Panasonic Healthcare Holdings and KKR, has signed a 10-year lease for 43,534 square feet at 5 Wood Hollow Road. The Mack-Cali Realty Corp.-owned property is a 317,040-square-foot, three-story, Class A office building. Bringing a company like Ascensia to our township is validation of the business-friendly environment we are cultivating here that brings a significant and positive economic impact, Parsippany Mayor James R. Barberio said in a prepared statement. We welcome the new jobs and look forward to Ascensia calling Parsippany home for a long time to come. The site was chosen because of its proximity to Bayer AG in Whippany, Ascensias former parent company. Panasonic and KKR acquired Bayers diabetes care business Jan. 5 and created the standalone company to develop, manufacture, market and sell blood glucose monitor meters and strips. The proximity to the Bayer Whippany location was also an important factor, as we wanted the new Ascensia U.S. headquarters to be located in a nearby area, in order to minimize any additional burden on our employees due to the change in location, said Robert Schumm, Ascensias vice president and managing director. Click here to subscribe to the NJBIZ Daily and other newsletters The building offers easy access to highways, located at the nexus of Interstate 287 and I-80, with I-280 and routes 202, 46 and 10 all nearby, according to Mack-Cali. This building is the ideal home for Ascensias U.S. headquarters, providing all the conveniences and services a company of this significance needs, said Christopher De Continue reading >>

Ascensia Diabetes Care Launches Smarter Version Of Contourdiabetes App With New Features To Support Self-management

Ascensia Diabetes Care Launches Smarter Version Of Contourdiabetes App With New Features To Support Self-management

Ascensia Diabetes Care Launches Smarter Version of CONTOURDIABETES App with New Features to Support Self-Management PARSIPPANY, New Jersey, May 8, 2018 /PRNewswire via COMTEX/ --PARSIPPANY, New Jersey, May 8, 2018 /PRNewswire/ -- Today, Ascensia Diabetes Care has announced the launch of its upgraded version of the CONTOUR [] DIABETES app in the United States. This latest version includes the new My Patterns feature, which uses innovative algorithms to more intelligently analyze blood glucose results received from the CONTOUR [] NEXT ONE meter, and delivers personalized meaningful feedback to patients. This feedback is designed to help patients improve diabetes self-management and maintain positive lifestyle changes. This new release will be available from today in the Apple App Store (iOS) and Google Play (Android), and is now available in 24 countries worldwide. (Photo: ) The CONTOUR [] DIABETES app was first launched in 2016 and is designed to seamlessly connect to the CONTOUR [] NEXT ONE meter [[] [+] []] . The My Patterns feature on the upgraded CONTOUR [] DIABETES app analyzes data received from the meter to identify and notify the user of sub-optimal patterns in their blood glucose readings. Once it has notified the user that a pattern has been identified, the CONTOUR [] DIABETES app will prompt users about the possible causes of the pattern and provide guidance to help address it. It allows patients to set reminders or use testing plans to help improve their blood glucose patterns, and will track their progress to see if the pattern improves over time*. The latest version of the app includes the ability to recognize 14 different patterns and use 11 different structured testing plans. The app will continue to evolve in the future to include additional patterns an Continue reading >>

Ascensia Diabetes Care Receives Fda Clearance For The App-enabled Contour Next One Blood Glucose Monitoring System

Ascensia Diabetes Care Receives Fda Clearance For The App-enabled Contour Next One Blood Glucose Monitoring System

Ascensia Diabetes Care Receives FDA Clearance For The App-Enabled CONTOUR NEXT ONE Blood Glucose Monitoring System Parsippany,NJ/PRNewswire/ - Ascensia Diabetes Care announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the CONTOUR NEXT ONE Blood Glucose Monitoring System (BGMS), marking a key step in making the next-generation system available to people living with diabetes in the U.S. The CONTOUR NEXT ONE system features an easy-to-use blood glucose smart meter which links to a mobile device via Bluetoothconnectivity. The meter connects to the CONTOURTM DIABETES app, a mobile app that collects, stores and analyzes patient blood glucose measurements delivered to it by the meter. The blood glucose measurements can be used to identify patterns and trends that may help patients understand how certain aspects of their daily activities affect their blood glucose. Robert Schumm, Head of Ascensia Diabetes Care US, said: "This is an innovative new option for people living with diabetes. The system combines the remarkable accuracy of the CONTOUR NEXT ONE meter with the easy-to-use features of the CONTOURTM DIABETES app and is designed to provide insights that may help people manage their diabetes in a better way." He added: "We believe the future of healthcare lies in connecting points of care. The first step in that journey for diabetes is to provide a connected system which can add value for people living with diabetes. Today, fewer than two percent of people living with diabetes use a connected meter. CONTOUR NEXT ONE is designed to be simple-to-use, and can meet the needs of a broad group of users. The FDA clearance paves the way to providing this option for all those who may benefit from it." Ascensia Diabetes Care expects to make the CONT Continue reading >>

Home | Contour Next One | Ascensia Diabetes Care

Home | Contour Next One | Ascensia Diabetes Care

The protection and security of your personal data are important to Ascensia. This Privacy Statement tells you how we collect, use, share, and protect your personal data, and together with the website Terms and Conditions, applies to your use of www.contournextone.com . Our Website has been developed and is operated by Ascensia Diabetes Care US Inc. (Ascensia) of, 5 Wood Hollow Road, Parsippany, NJ, 07054 United States. Ascensia is a subsidiary of Ascensia Diabetes Care Holdings AG of Switzerland. Please read this Privacy Statement to understand how Ascensia may process your personal data provided via our Website, including any health-related information for which we will ask for your explicit consent before its collection. You are not required to provide any personal data as a condition of using our Website. However, Ascensia will process your personal data when you submit it in the following ways: Communications via our Website: We collect personal data when you provide it to us through communications via our Website. This includes completion of an online registration or webform, where you contact us with an enquiry or request and similar situations in which you have chosen to provide the information to us, including for customer services support. Products or Services You Request: Where you request a product or service from us, we will collect your personal data in order to process your request. Our distributors may also share with us personal data that you provide to them when you buy an Ascensia product or otherwise contact them following a purchase. When you communicate with us via our Website or request a product or service, the types of information we may collect from you include: your name, gender, date of birth, contact details including your address, email add Continue reading >>

Ascensia Diabetes Care Inks Integration Deal With Insulet

Ascensia Diabetes Care Inks Integration Deal With Insulet

Ascensia Diabetes Care inked a new relationship with UnitedHealthcare(NYSE:UNH), the company touted today, which is designed to improve access to AscensiasContour Next blood glucose meters and test strips for UnitedHealthcare members. Now, people enrolled in UnitedHealthcares employer or commercial plans can get a meter or test trip through their pharmacy benefit at a Tier 2 [] Ascensia Diabetes Carehas expanded its partnership withInsulet(NSDQ:PODD) to include a global commercial deal. The two companies inked a world-wide development agreement in June last year to connect Ascensias Contour Next One blood glucose monitor with Insulets next-gen Omnipod system, Omnipod Dash. Get the full story at our sister site, Drug Delivery Business News. In support of World Diabetes Day earlier this month,Ascensia Diabetes Carepublished 30 portraits of women who are working to advance diabetes care. The companys CEO, Michael Kloss, said he was inspired by the theme of this years annual event,Women and Diabetes, and turned within the company for nominations of inspiring women. Get the full story [] Continue reading >>

Ascensia Diabetes Care (new Jersey / Switzerland)

Ascensia Diabetes Care (new Jersey / Switzerland)

Afrezza (insulin human [rDNA]. Insulin you can take. peaks in 12 to 15 mins, baseline 3 hours. blood glucose monitors with a wireless record. #Nasty Women. Really a white supremacist ? Post by lakers on Jan 31, 2016 14:33:57 GMT -5 Mack-Cali announces new lease with Ascensia Diabetes Care Global Leader in Blood Glucose Monitoring and Diabetes Care Solutions will Open U.S. Headquarters in Parsippany, NJ parsippanyfocus.com/2016/01/29/mack-cali-announces-new-lease-with-ascensia-diabetes-care/ Mayor is proud to announce for the 39th consecutive year, Parsippany has been named a Tree City. ... NJ Patch has put together a list of the "15 Safest Big Towns" in New Jersey and Parsippany-Troy Hills ranks among the top five. KKR, Panasonic form newco Ascensia from Bayer Diabetes buy for $1.1B Panasonic Healthcare has closed its purchase of the Bayer Diabetes Care business for about $1.1 billion. The deal was originally disclosed in June and was funded in part by well-known hedge fund KKR, which holds 80% of Panasonic Healthcare with the remainder owned by the larger Panasonic corporate entity. The acquired business will operate as a stand-alone company known as Ascensia Diabetes Care. Along with Panasonic Healthcare, the newco is expected to continue to develop, manufacture and market blood glucose monitoring meters and strips globally. "Our goal is to ensure high-quality technologies and diabetes care solutions are available to all patients who need them. Bringing together Panasonic Healthcare and Ascensia Diabetes Care will significantly help to achieve this goal," said the President of Panasonic Healthcare Hidehito Kotani in a statement. Sign up for our FREE newsletter for more news like this sent to your inbox! He continued, "Together with KKR, the companies will be able to Continue reading >>

Ascensia Diabetes Goes Toward Future

Ascensia Diabetes Goes Toward Future

PARSIPPANY, N.J. Ascensia Diabetes Care has upgraded its Contour Diabetes app to help users self-manage their diabetes better by analyzing behavior patterns and suggesting new ones. This behavior-change approach helps patients understand what the trends are, what the data means, and then provides personalized feedback so they can make the changes that they need to, said Robert Schumm,head of region Americasof Ascensia Diabetes Care. Originally released in 2016 to connect to the Contour Next One meter and help users log their diet and exercise, the latest version uses algorithms to identify four different patterns: critical (extreme highs and lows requiring immediate medical attention), recent highs and lows, mealtimes and days of the week. Once the patient is made aware of a negative trend, the app offers possible causes for the dip or spike, such as food, medicine or exercise, followed by recommendations on how to address the pattern. When the trend is corrected, the app motivates the patient with positive recognition. When we developed the product, we worked with a psychologist who studied chronic disease management and how patients got better outcomes, said Schumm. The model we used is called the Information, Motivation and Behavioral Skills (IMB) model and you need all three of these pieces to affect real change. Going forward, Schumm sees the app evolving to provide personalized coaching and disease management based onmultiple sources of data, such as continuous monitoring data, exercise/activity data and blood pressure readings, not just blood glucose levels.He also sees that data being shared. Weve come a long way in terms of blood glucose monitoring, but if everyonehealthcare professionals, nurses, caregiversis able to see that data and use it effectively, youl Continue reading >>

9 Best Company:

9 Best Company:"ascensia Diabetes Care" Jobs In Parsippany, Nj (hiring Now!) | Simply Hired

Ascensia Diabetes Care - Troy Hills, NJ4.3 Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes.... Ascensia Diabetes Care - Troy Hills, NJ4.3 Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes.... Ascensia Diabetes Care - Troy Hills, NJ4.3 Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes.... Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures. Ascensia Diabetes Care - Troy Hills, NJ4.3 Ascensia Diabetes Care is a global diabetes care company, dedicated to helping improve the lives of people with diabetes by empowering them to take charge of... Ascensia Diabetes Care - Troy Hills, NJ4.3 Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes.... Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures. Ascensia Diabetes Care - Troy Hills, NJ4.3 Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes.... Ascensia Diabetes Care - Troy Hills, NJ4.3 Ascensia Diabetes Care is a global specialist diabetes care company, dedicated Continue reading >>

Ascensia | Contact Us

Ascensia | Contact Us

If you are a customer, job-seeker, partner or journalist, please use this section to find contact information and details about our regional corporate offices around the world. Questions or comments about this website, please CLICK HERE. An adverse event is any unwanted medical occurrence in a patient who has been given a pharmaceutical product or medical device. This can be any unfavourable and/or unintended sign, symptom, or complication associated with the use of the product. Adverse events should be reported immediately to a healthcare professional. Adverse events associated with an Ascensia Diabetes Care product should also be reported to Ascensia Diabetes Care contact details below: If you have any questions about the latest available blood glucose solutions, contact Ascensia Diabetes Care in your country. Visit contact.ascensia.com for a full listing of countries. Questions or comments about this website, please CLICK HERE. If you have any questions about the latest available blood glucose solutions, contact Ascensia Diabetes Care in your country. Visit contact.ascensia.com for a full listing of countries. Questions or comments about this website, please CLICK HERE. Please note that not all products are available in every country. The company that brings you CONTOURproducts now has a new name. Introducing Ascensia Diabetes Care. Ascensia, the Ascensia Diabetes Care logo and CONTOUR are trademarks of Ascensia Diabetes Care Holdings AG. Copyright 2017 Ascensia Diabetes Care Holdings AG. All rights reserved. Last updated: July 2016. Code: G.DC.01.2016.37920 Please note that not all products are available in every country. The company that brings you CONTOURproducts now has a new name. Introducing Ascensia Diabetes Care. Ascensia, the Ascensia Diabetes Care logo and Continue reading >>

Ascensia Diabetes Care Launches Contournext Link 2.4 Wireless Blood Glucose Monitoring System As Part Of The Medtronic Minimed 630g System With Smartguard Technology

Ascensia Diabetes Care Launches Contournext Link 2.4 Wireless Blood Glucose Monitoring System As Part Of The Medtronic Minimed 630g System With Smartguard Technology

Ascensia Diabetes Care Launches CONTOURNEXT LINK 2.4 Wireless Blood Glucose Monitoring System as Part of the Medtronic MiniMed 630G System with SmartGuard Technology August 11, 2016 07:03 AM Eastern Daylight Time PARSIPPANY, N.J.--( BUSINESS WIRE )--Ascensia Diabetes Care has today announced the commercial launch and approval from the U.S. Food and Drug Administration (FDA) of the CONTOURNEXT LINK 2.4 Blood Glucose Monitoring System (BGMS) as part of the Medtronic MiniMed 630G system with SmartGuard technology. The MiniMed 630G system is an integrated insulin pump with Continuous Glucose Monitoring (CGM) and SmartGuardTM technology. CONTOURNEXT LINK 2.4 is the only BGMS that is FDA approved for use as part of the MiniMed630G system with SmartGuard technology. The CONTOURNEXT LINK 2.4 BGMS wirelessly sends highly accurate blood glucose results for CGM calibration and insulin dosing, and is designed exclusively for use with the MiniMed 630G system with SmartGuard technology. The CONTOURNEXT LINK 2.4 BGMS automatically transmits blood glucose results into the MiniMed 630G pump, eliminating manual blood glucose entry errors to the pump, which often can result in an incorrect bolus calculation on the pump. The meter also allows patients to discreetly give a bolus of insulin remotely from the meter to the pump, providing added ease of use and convenience and ease of use for patients using this system. We are delighted that the MiniMed630G system with the CONTOURNEXT LINK 2.4 Meter will now be available to people with diabetes in the United States, stated Robert Schumm, President of Ascensia Diabetes Care US Inc. The accuracy of our blood glucose monitoring system combined with the new innovative technology of the MiniMed 630G system will truly help people with diabetes manag Continue reading >>

Product Quality Engineer

Product Quality Engineer

Ascensia Diabetes Care19 reviews-Troy Hills, NJ Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes. Our mission is to empower people living with diabetes through innovative solutions that simplify and improve their lives. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a positive, daily difference for people with diabetes. POSITION PURPOSE:This position combines quality engineering input to software-based quality processes with systems administration of the associated applications. The position includes quality oversight of the review and release of Engineering Change Orders (ECOs), control of product quality engineering documentation, management of the Ascensia UDI Production Database and developing metrics for monitoring and improving process performance. As a member of project teams, this position supports drafting of business requirements, developing validation plans/reports and executing testing. This position ensures compliance with regulatory requirements for product documentation while supporting business needs. MAJOR TASKS AND RESPONSIBILITIES OF POSITION: UDI Production Database System Administrator + Assists in supplier setup of UDI Production Database, and resolves supplier data upload inconsistencies to database + Develops validation documentation and conducts validation testing for system software changes. + Provides training to suppliers and contract manufacturers + Performs process/procedure updates supporting improved functionality and new country roll-outs Document Management Systems Administrator (Product Quality Engineering Documentation) + Develops solutions for managing new documentation types + Provides process impro Continue reading >>

More in diabetes